lenacapavir yeztugo - Search News

News

HIV, lenacapavir and FDA

CBS News on MSN · 2d

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Public Broadcasting Service (PBS) · 14h

6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.

The Financial Express · 22m

US FDA approves twice-a-year HIV shot that could end daily pills

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn shrinking health budgets may limit access in high-risk areas.

2hon MSN

Here’s what everyone should know about this new HIV prevention shot

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

Audacy on MSN13h

There's a new, highly effective HIV drug on the market

A revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...

Managed Healthcare Executive1d

With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results